57 related articles for article (PubMed ID: 15232166)
21. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
[TBL] [Abstract][Full Text] [Related]
22. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
Wagenlehner FM; Lehn N; Witte W; Naber KG
Chemotherapy; 2005 May; 51(2-3):64-9. PubMed ID: 15870498
[TBL] [Abstract][Full Text] [Related]
24. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
Noviello S; Ianniello F; Leone S; Esposito S
J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
[TBL] [Abstract][Full Text] [Related]
25. In vitro brodimoprim activity on bacterial strains.
Benoit-Lemercier C; Bergogne-Bérézin E; Joly-Guillou ML
J Chemother; 1993 Dec; 5(6):435-43. PubMed ID: 8195835
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic susceptibility of conjunctival bacterial isolates from refractive surgery patients.
Chung JL; Seo KY; Yong DE; Mah FS; Kim TI; Kim EK; Kim JK
Ophthalmology; 2009 Jun; 116(6):1067-74. PubMed ID: 19395038
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
Farrell DJ; Robbins M; Rhys-Williams W; Love WG
Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
[TBL] [Abstract][Full Text] [Related]
28. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina.
Fernández Canigia L; Kaufman S; Lanata L; Vay C; Giovanakis M; Bantar C;
Chemotherapy; 2009; 55(1):20-7. PubMed ID: 18974645
[TBL] [Abstract][Full Text] [Related]
29. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
Streit JM; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and SAR Studies of Antibacterial Peptidyl Derivatives Based upon the Binding Site of Human Cystatin C.
Dzierżyńska M; Sikorska E; Pogorzelska A; Mulkiewicz E; Sawicka J; Wyrzykowski D; Małuch I; Grubb A; Kasprzykowski F; Rodziewicz-Motowidło S
Protein Pept Lett; 2019 Jul; 26(6):423-434. PubMed ID: 30864495
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antibacterial properties of peptidyl derivatives and cyclopeptides structurally based upon the inhibitory centre of human cystatin C. Dissociation of antiproteolytic and antibacterial effects.
Kasprzykowski F; Schalén C; Kasprzykowska R; Jastrzebska B; Grubb A
APMIS; 2000; 108(7-8):473-81. PubMed ID: 11167542
[TBL] [Abstract][Full Text] [Related]
32. Cystatin C peptidomimetic derivative with antimicrobial properties as a potential compound against wound infections.
Pikuła M; Smużyńska M; Krzystyniak A; Zieliński M; Langa P; Deptuła M; Schumacher A; Łata J; Cichorek M; Grubb A; Trzonkowski P; Kasprzykowski F; Rodziewicz-Motowidło S
Bioorg Med Chem; 2017 Feb; 25(4):1431-1439. PubMed ID: 28110818
[TBL] [Abstract][Full Text] [Related]
33. Novel antibiotics for the treatment of gram-positive bacterial infections.
Brands M; Endermann R; Gahlmann R; Krüger J; Raddatz S; Stoltefuss J; Belov VN; Nizamov S; Sokolov VV; de Meijere A
J Med Chem; 2002 Sep; 45(19):4246-53. PubMed ID: 12213065
[TBL] [Abstract][Full Text] [Related]
34. In vitro antimicrobial activity of a new series of 1,4-naphthoquinones.
Riffel A; Medina LF; Stefani V; Santos RC; Bizani D; Brandelli A
Braz J Med Biol Res; 2002 Jul; 35(7):811-8. PubMed ID: 12131921
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial activities of fluorovinyl- and chlorovinylglycine and several derived dipeptides.
Patchett AA; Taub D; Weissberger B; Valiant ME; Gadebusch H; Thornberry NA; Bull HG
Antimicrob Agents Chemother; 1988 Mar; 32(3):319-23. PubMed ID: 3284459
[TBL] [Abstract][Full Text] [Related]
36. The usnic acid derivative peziculone targets cell walls of Gram-positive bacteria revealed by high-throughput CRISPRi-seq analysis.
Zhang H; Li X; Liu X; Ji X; Ma X; Chen J; Bao Y; Zhang Y; Xu L; Yang L; Wei X
Int J Antimicrob Agents; 2023 Sep; 62(3):106876. PubMed ID: 37276892
[TBL] [Abstract][Full Text] [Related]
37. THE ANTIBACTERIAL PROPERTIES OF SULFUR.
Weld JT; Gunther A
J Exp Med; 1947 Apr; 85(5):531-42. PubMed ID: 19871634
[TBL] [Abstract][Full Text] [Related]
38. The occurrence of polyglycerophosphate as an antigenic component of various gram-positive bacterial species.
McCARTY M
J Exp Med; 1959 Apr; 109(4):361-78. PubMed ID: 13641562
[TBL] [Abstract][Full Text] [Related]
39. A Novel Derivative of Thioridazine Shows Low Toxicity and Efficient Activity against Gram-Positive Pathogens.
Jørgensen NS; Saaby L; Andersson AM; Kromann S; Sheikhsamani E; Permin A; Ronco T; Svenningsen SW; Christensen JB; Olsen RH
Antibiotics (Basel); 2020 Jun; 9(6):. PubMed ID: 32549350
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.
Deslouches B; Di YP
Oncotarget; 2017 Jul; 8(28):46635-46651. PubMed ID: 28422728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
